CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Biomérieux third-quarter organic sales growth beats expectations

By Reuters News

Nov 3 (Reuters) - French biotechnology firm Biomérieux BIOX.PA reported on Tuesday a better-than-expected organic sales growth in the third quarter, helped by a 13% increase across key growth areas under its GO28 strategic plan.

Total sales for the period came in at €1,042 million ($1.17 billion), up 8% year on year, above the company's compiled median consensus for sales of €1,007 million and organic growth of 5.9%.

  • Year-on-year growth at Clinical Applications, which make up 84% of total sales, reached 8% in the quarter, while Industrial Applications, 16% of sales, grew by 9%

  • BIOFIRE Non-Respiratory panels sales increased by 25% driven by "strong momentum across the entire portfolio", with the cyclosporiasis outbreak in the US boosting demand for BIOFIRE gastrointestinal panel

  • Biomérieux confirmed its guidance for the full year but added that it now expects a negative currency effect of about €35 million versus the earlier forecast of negative €40-50 million

  • The company, which targets organic sales growth of 3%-6% per year in 2027 and 2028, aims to expand into women’s health with a new vaginitis panel set to enter the US market in early 2027

($1 = 0.8937 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.